Biomarkers predictive of PD1/PD-L1 immunotheraphy in non-small cell lung cancer

被引：4

作者：

Lupo, A. ^{[1
,2
,3
,4
]}

Alifano, M. ^{[2
,5
]}

Wislez, M. ^{[1
,2
,3
,4
,6
]}

Boulle, G. ^{[1
,2
,3
]}

Velut, Y. ^{[1
,2
,3
]}

Biton, J. ^{[7
]}

Cremer, I. ^{[1
,2
,3
]}

Goldwasser, F. ^{[2
,8
]}

Leroy, K. ^{[2
,9
]}

Damotte, D. ^{[1
,2
,3
,4
]}

机构：

[1] INSERM, UMRS 1138, Equipe Canc Immune Control & Escape, Ctr Rech Cordeliers, Paris, France

[2] Univ Paris 05, F-75006 Paris, France

[3] Univ Pierre & Marie Curie Paris, F-75005 Paris, France

[4] Hop Cochin, AP HP, Serv Pathol, F-75014 Paris, France

[5] Hop Cochin, AP HP, Serv Chirurg Thorac, F-75014 Paris, France

[6] Hop Tenon, AP HP, Serv Pneumol, F-75014 Paris, France

[7] Univ Paris 13, Sorbonne Paris Cite, Lab Immunol & Immunopathol Li2P, Inserm UMR 1125,Physiopathol Cibles & Therapies P, F-93000 Bobigny, France

[8] Hop Cochin, AP HP, Serv Oncol Med, F-75014 Paris, France

[9] Hop Cochin, AP HP, Serv Genet & Biol Mol, F-75014 Paris, France

来源：

REVUE DE PNEUMOLOGIE CLINIQUE | 2018年 / 74卷 / 05期

关键词：

Lung cancer; Biomarkers; Immune checkpoint inhibitors; Immunotherapy; PULMONARY SQUAMOUS-CELL; PD-1; BLOCKADE; ANTI-PD-L1; ANTIBODY; CLINICAL-RESPONSE; CTLA-4; OPEN-LABEL; EXPRESSION; IMMUNOHISTOCHEMISTRY; MICROENVIRONMENT; MULTICENTER;

D O I：

10.1016/j.pneumo.2018.09.010

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Immune checkpoint inhibitors (ICI), targeting the PD1/PD-L1 axis has shown their efficacy in lung cancer but only in a restricted population of patients, thus it is mandatory to identify biomarkers predicting the clinical benefit. In this article we will describe and analyzed biomarkers already published, from protein, to RNA and at last DNA markers, discussing each markers feasibility and interest. In the future, combined analysis of several markers will probably be proposed, particularly with the increasing complexity of therapy schema with molecules association. (C) 2018 Elsevier Masson SAS. All rights reserved.

引用

页码：339 / 350

页数：12

共 50 条

[31] Plasma Proteomic Analysis in Non-Small Cell Lung Cancer Patients Treated with PD-1/PD-L1 Blockade [J].

Eltahir, Mohamed ;

Isaksson, Johan ;

Mattsson, Johanna Sofia Margareta ;

Karre, Klas ;

Botling, Johan ;

Lord, Martin ;

Mangsbo, Sara M. ;

Micke, Patrick .

CANCERS, 2021, 13 (13)

[32] The progress and confusion of anti-PD1/PD-L1 immunotherapy for patients with advanced non-small cell lung cancer [J].

Zhang, Shuling ;

Bai, Xueli ;

Shan, Fengping .

INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 80

[33] Clinical efficacy and safety of anti-PD-1/PD-L1 treatments in non-small cell lung cancer (NSCLC) [J].

Zeng, Tian ;

Qin, Qin ;

Bian, Zhiheng ;

Li, Jianjun .

ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2019, 47 (01) :4194-4201

[34] PD1 and PD-L1 Inhibitors for the Treatment of Kidney Cancer: The Role of PD-L1 Assay [J].

Cimadamore, Alessia ;

Massari, Francesco ;

Santoni, Matteo ;

Lopez-Beltran, Antonio ;

Cheng, Liang ;

Scarpelli, Marina ;

Montironi, Rodolfo ;

Moch, Holger .

CURRENT DRUG TARGETS, 2020, 21 (16) :1664-1671

[35] Quantification of PD-L1 expression in non-small cell lung cancer [J].

Verma, Vivek ;

Chang, Joe Y. .

TRANSLATIONAL CANCER RESEARCH, 2017, 6 :S402-S404

[36] Current PD-L1 immunohistochemistry for non-small cell lung cancer [J].

Scheel, Andreas H. ;

Schaefer, Stephan C. .

JOURNAL OF THORACIC DISEASE, 2018, 10 (03) :1217-1219

[37] Molecular regulatory network of PD-1/PD-L1 in non-small cell lung cancer [J].

Zhu, Lingling ;

Lin, Jiewei ;

Wang, Li ;

Yan, Danli ;

Zhou, Jie ;

Li, Wen ;

Pu, Dan ;

Peng, Lei ;

Zhou, Qinghua .

PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (04)

[38] PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability [J].

Munari, Enrico ;

Zamboni, Giuseppe ;

Marconi, Marcella ;

Sommaggio, Marco ;

Brunelli, Matteo ;

Martignoni, Guido ;

Netto, George J. ;

Moretta, Francesca ;

Mingari, Maria Cristina ;

Salgarello, Matteo ;

Terzi, Alberto ;

Picece, Vincenzo ;

Pomari, Carlo ;

Lunardi, Gianluigi ;

Cavazza, Alberto ;

Rossi, Giulio ;

Moretta, Lorenzo ;

Bogina, Giuseppe .

ONCOTARGET, 2017, 8 (52) :90123-90131

[39] Characteristics and Predictive Value of PD-L1 Status in Real-World Non-Small Cell Lung Cancer Patients [J].

Tseng, Jeng-Sen ;

Yang, Tsung-Ying ;

Wu, Chih-Ying ;

Ku, Wen-Hui ;

Chen, Kun-Chieh ;

Hsu, Kuo-Hsuan ;

Huang, Yen-Hsiang ;

Su, Kang-Yi ;

Yu, Sung-Liang ;

Chang, Gee-Chen .

JOURNAL OF IMMUNOTHERAPY, 2018, 41 (06) :292-299

[40] Inter-tumor heterogeneity of PD-L1 expression in non-small cell lung cancer [J].

Saito, Yuichi ;

Horiuchi, Sho ;

Morooka, Hiroaki ;

Ibi, Takayuki ;

Takahashi, Nobumasa ;

Ikeya, Tomohiko ;

Shimizu, Yoshihiko ;

Hoshi, Eishin .

JOURNAL OF THORACIC DISEASE, 2019, 11 (12) :4982-4991

← 1 2 3 4 5 →